TechNation Radio hosted by Dr Moira Gunn
…
continue reading
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
…
continue reading
A new segment on Tech Nation - Tech Nation Health!
…
continue reading
BioTech Nation Radio with Dr Moira Gunn
…
continue reading
Dr. Robert Coleman, CEO of Codagenix, discusses their innovative approach to virus engineering, which includes developing a nasally-delivered COVID-19 vaccine that targets multiple virus proteins for broader protection. Codagenix's "rational virus design" method creates genetically stable vaccines and therapeutics, reducing the risk of harmful muta…
…
continue reading
On this week’s Tech Nation, Moira speaks with Clinical Psychologist and Author Dr. Ramani Durvasula about how to heal from Narcissists in your life and her book, “It’s Not You … Identifying and Healing from Narcissistic People”. Then, regular contributor and author of, “Rest: Why You Get More Work Done, When You Work Less.”, Dr. Alex Pang, talks ab…
…
continue reading
On this week’s Tech Nation, Moira speaks on the ability to monitor both our health … and our illnesses. Even the ability to see if our medical condition is changing or that last update in prescription really worked. And what about when you travel? Dr. Kal Patel is the Co-Founder and CEO of BrightInsight. He tells us about the challenges and BrightI…
…
continue reading
Continuous monitoring ... when we want it, when we don’t, should we share it? Or not. Or perhaps just part of it. Dr. Kal Patel, the Co-Founder and CEO of BrightInsight talks about this brave new frontier.Por Moira Gunn
…
continue reading
1
Can the Mapping of Human Biology Lead to Better Drugs? Dr. Chris Gibson, Co-Founder & CEO Recursion Pharmaceuticals
21:42
Dr. Chris Gibson, the co-founder and CEO of Recursion Pharmaceuticals in Salt Lake City. We talk about their efforts to map ALL of human biology, and how this mapping will lead to better drugs.Por Moira Gunn
…
continue reading
On this week’s Tech Nation, Moira speaks with Duke University Professor Nita Farahany about her book, “The Battle for Your Brain … Defending the Right to Think Freely in the Age of Neurotechnology.” Then recovering from the devastation of war, Conservation X Lab’s Dr. Alex Dehgan talks about his book, “The Snow Leopard Project … and other Adventure…
…
continue reading
1
One Company, Two Different Drugs - It's All About Glucose - Too Much and Too Little! Nevan Charles Elam, Founder & CEO, Rezolute
18:52
Glucose is essential for life. And the insulin we produce is designed to leave just the right of amount in our bodies for healthy functioning. Thus, when we underproduce insulin - or we overproduce it - the results can be devastating. Nevan Charles Elam, Founder and CEO of Rezolute, tells us about their work to treat the “diabetic eye condition”, D…
…
continue reading
This week on BioTech Nation, Dr. Amit Kumar, President and CEO of Anixa Biosciences, talks about their work on a breast cancer vaccine which targets a protein thought only to be expressed during breastfeeding. Building on research by the Cleveland Clinic, Dr. Kumar describes ongoing human clinical trials and their potential for women with BRCA muta…
…
continue reading
On this week’s Tech Nation, Moira speaks with Columbia professors Chris Wiggins and Matthew Jones about their book, “How Data Happened … A History from the Age of Reason to the Age of Algorithms.” Then it’s all about glucose at Rezolute – too much and too little. Nevan Charles Elam tells us about their work in treating the “diabetic eye condition”,…
…
continue reading
On this week’s Tech Nation, Moira speaks with Bruce Schoenfeld, journalist and author of “Game of Edges …The Analytics Revolution and the Future of Professional Sports.”, about the data revolution in professional sports.
…
continue reading
This week on Biotech Nation, Dr. Noah Davidsohn, Co-Founder and Chief Scientific Officer of Rejuvenate Bio. The discussion centers around the regulation of protein expression and its implications for aging and health. Dr. Davidsohn explains how aging disrupts the balance of protein production, leading to various diseases. Rejuvenate Bio's gene ther…
…
continue reading
On this week’s Tech Nation, Moira speaks with Semafor Editor-in-Chief and former founding editor-in-chief of Buzzfeed News, Ben Smith, about his book, “Traffic … Genius, Rivalry, and Delusion in the Billion Dollar Race to Go Viral”. Then, Dr. Peter Diamandis, The Executive Chair of the XPrize Foundation, and host of the Moonshots podcast, about ext…
…
continue reading
This week of BioTech Nation, Dr. Peter Diamandis about his new book, "Longevity: Your Practical Playbook on Sleep, Diet, Exercise, Mindset, Medications, and Not Dying from Something Stupid". We explore his lifelong interest in extending human health span and discuss practical steps for a healthier, longer life, including sleep, diet, exercise, and …
…
continue reading
On this week’s Tech Nation, Moira speaks with Co-Founder and Co-CEO of NewsGuard, Steven Brill about his book, “The Death of Truth” about the negative impact of the Internet and Social Media and what we can do about it. Then, what science tells us about the treatment potential of Hallucinogens without the hallucinations with, Dr. Sam Clark, CEO of …
…
continue reading
This week on BioTech Nation, Dr. Sam Clark, CEO of Terran Biosciences, discusses prodrugs—modified drugs that improve absorption and efficacy. Also, Terran Biosciences is developing non-hallucinogenic psychedelics by blocking the serotonin 2A receptor and manufacturing psychedelics like LSD and psilocybin for research. Dr. Clark highlights Terran's…
…
continue reading
This week on Biotech Nation, Dr. Marianne De Backer, CEO of Vir Biotechnology talks about their Phase 2 clinical trials targeting hepatitis B and D co-infections. Vir's approach uses two drugs: tobevibart (an antibody) and elebsiran (an siRNA). These drugs prevent the virus from entering liver cells and stop it from replicating. Preliminary results…
…
continue reading
Neuroscientist and Author Dr. Kelly Clancy joins me to discuss the role that games have played in human development. Her book is “Playing with Reality … How Games Have Shaped Our World.” Then, Dr. Marianne De Backer, CEO of Vir Biotechnology, explains how serious it can be when a person carries both Hepatitis B and Hepatitis D and what Vir is doing…
…
continue reading
On this week’s Tech Nation, Moira speaks with Author, Elaine Lin Hering, joins me to talk about her book, “Unlearning Silence … How to Speak Your Mind, Unleash Talent, and Live More Fully.” Then, Dr. Neil Kumar, Founder and CEO of BridgeBio Pharma, explains why we can expect genetic diseases to be solvable in our lifetime.…
…
continue reading
This week on Biotech Nation, Dr. Neil Kumar, founder and CEO of BridgeBio Pharma. Dr. Kumar emphasizes that genetic diseases, particularly Mendelian diseases caused by single gene mutations, are solvable due to advancements in genetic measurement and understanding. He discusses BridgeBio Pharma's innovative corporate structure, which consists of mu…
…
continue reading
On this week’s Tech Nation, Moira speaks with Stanford Business School Lecturer, Matt Abrahams, about his book, “THINK FASTER, TALK SMARTER: How To Speak Successfully When You’re Put on the Spot”. Then, Dr. Steffen-Sebastian Bolz from Aphaia Pharma talks about their new drug, currently in phase 3 trial, that may provide the benefits of Ozempic and …
…
continue reading
1
The Next Ozempic or Wegovy... But Without the Injection??? Dr. Steffen-Sebastian Bolz, CSO, Aphaia Pharma
25:16
What’s next after Ozempic and Wegovy and the like? How about a drug in development which releases all the relevant hormones, and not just GLP-1. And doesn’t require injecting. Dr. Steffen-Sebastian Bolz from Aphaia (ah-phi-ah) Pharma explains their approach, currently in Phase 2.Por Moira Gunn
…
continue reading
1
FDA Approval! A New Model for BioPharma... Dr. Sam Blackman, Founder & Head of Research and Development, Day One Biopharmaceuticals
31:10
This week on BioTech Nation, Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals, shares the story behind the FDA approval of a groundbreaking drug for the most common childhood brain cancer. He talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved dru…
…
continue reading
This week we have a best of rerun with Dr. Mark Sumeray from Amolyt Pharma. Dr. Sumeray talks about their innovative approach to treating hormonal conditions. We’ll talk about two – when your parathyroid has been injured or removed, often during thyroid surgery, and another – when the pituitary starts overproducing growth hormone.…
…
continue reading
Stanford Professor Robert Sapolsky about “Determined: A Science of Life Without Free Will”. Then, Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about how Medical Schools decide what to teach.
…
continue reading
On this week’s Tech Nation, Moira speaks with Journalist Alex Kantrowitz about his 2020 book, “Always Day One: How the Tech Titans Plan to Stay on Top Forever” which has spawned his work, as Founder and Editor of Big Technology. Then, Dr. Mark Sumeray, Chief Medical Officer of Amolyt Pharma, talks about their innovative approach to treating hormona…
…
continue reading
This week Dr. Daniel Kraft, Tech Nation Health Chief Correspondent, discusses advanced health tech. Dr. Kraft highlights his use of wearables like the Apple Watch, Oura ring, and non-invasive blood pressure monitors. He also introduces "otherables," which track health without being worn, using devices like cameras and modified WiFi. These technolog…
…
continue reading
On this week’s Tech Nation, Moira speaks with Science journalist and author, Annalee Newitz, joins me to talk about her book, “Stories are Weapons … Psychological Warfare and the American Mind”. Then, Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about the latest in Wearables, what they are doing now that they weren’t doing before.…
…
continue reading
This week on BioTech Nation, Dr. Moira Gunn and Dr. Daniel Kraft discuss how robotics, AI, and virtual reality are transforming surgery. These technologies make procedures less invasive and improve training and outcomes worldwide. Future advancements may include tiny robots performing internal procedures. Security is crucial to prevent hacking of m…
…
continue reading
On this week’s Tech Nation, Moira speaks with Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved drug that treats the most common form of brain cancer in children. Then, Dr. Daniel Kraft, Tech Nati…
…
continue reading
On this week’s Tech Nation, Moira speaks with Mustafa Suleyman, CEO of Inflection AI, about “The Coming Wave … Technology, Power, and the 21st Century’s Greatest Dilemma”. Then, Bloomberg columnist Adam Minter talks about his 2019 book, “Secondhand: Travels in the New Global Garage Sale.” You dropped it off at the thrift store … where does it go fr…
…
continue reading
Dr. John Scarlett, President and CEO of Geron Corporation talks about their drug Imetelstat for myelodysplastic syndrome (MDS). MDS patients often require frequent blood transfusions, impacting their quality of life. Imetelstat, a telomerase inhibitor, aims to reduce transfusion dependence by targeting cancer cells in the bone marrow. Phase three t…
…
continue reading
On this week’s Tech Nation, Moira speaks with Sports ecology professor and author Dr. Madeleine Orr, about her book, “Warming Up… How Climate Change is Changing Sport”. Then, Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about the Medical Innovation Gap, which is the time from innovation until we actually can use it in everyday prac…
…
continue reading
Dr. Daniel Kraft, Tech Nation Health Chief Correspondent discusses the gap between medical innovation and its adoption into standard practice. He highlights that it typically takes 17 years for a medical discovery to become common practice, but big data and AI could accelerate this. He emphasizes the importance of sharing medical data and initiativ…
…
continue reading
This week, Dr. Steve Quake from the Chan Zuckerberg Initiative about their goal to tackle all human diseases in the next century. We discuss CZI's innovative approach, including building Biohubs and funding collaborative research. Dr. Quake explains the importance of something called The Virtual Cell project, aiming to use AI to model every human c…
…
continue reading